Thermostable Cas9 nucleases

US12071639B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12071639-B2
Application numberUS-201716469691-A
CountryUS
Kind codeB2
Filing dateDec 14, 2017
Priority dateDec 14, 2016
Publication dateAug 27, 2024
Grant dateAug 27, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polynucleotide encoding a ThermoCas9 protein from Geobacillus thermodenitrificans and a constitutive promoter are used to engineer eukaryotic cells, e.g. fungi, yeast or algae, so that the ThermoCas9 endonuclease is integrated and expressed from the genome of the cell. Then, a second expression plasmid is used to transfect these ThermoCas9 expressing cells, the second plasmid containing an inducible promoter and a polynucleotide encoding a guide RNA. The guide RNA combines with the ThermoCas9 to provide the targeted endonuclease activity to cleave the cell DNA at a desired locus or gene of interest. A repair-oligo is also provided to the cell whereby following DNA cleavage, homologous recombination takes place in the cell with the repair-oligo so that either a deletion or substitution of nucleotides in the locus or gene of interest is achieved. Expression vectors and methods of using the vectors to achieve ThermoCas9 mediated gene editing are described whereby higher temperatures, e.g. greater than 30° C., are used.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polynucleotide expression vector for modifying the genetic material at a target locus of a host organism which comprises the expression vector, the vector comprising: a) a polynucleotide sequence encoding a ThermoCas9 nuclease, wherein the ThermoCas9 nuclease comprises the amino acid sequence of SEQ ID NO: 1 or a sequence of at least 89% identity therewith, or an active fragment thereof; b) a polynucleotide sequence encoding a guide RNA, wherein the guide RNA has a nucleic acid sequence which recognizes a target nucleic acid sequence comprised in the target locus; and c) a first promoter oriented with respect to polynucleotide sequences of (a) and (b) so as to drive expression thereof in the organism, wherein said first promoter is an inducible promoter. 2. The vector as claimed in claim 1 , wherein the sequence of (a) is 3′ of the promoter and the sequence of (b) is 3′ of the sequence of (a). 3. The vector as claimed in claim 1 , wherein the first promoter is selected from the group consisting of a β-glucosidase promoter inducible with cellobiose and a Pm promoter inducible with 3-methylbenzoate. 4. The vector as claimed in claim 1 , further comprising a homologous recombination (HR) fragment comprising at least one HR recombination arm. 5. The vector as claimed in claim 4 , wherein the HR fragment comprises two recombination arms which allow recombination upstream and downstream, respectively, of a locus of interest in the host organism; and further wherein the locus of interest comprises the target sequence. 6. The vector as claimed in claim 5 , wherein the HR fragment further comprises an insertion element between the upstream and downstream arms thereof; wherein the insertion element comprises a gene of interest. 7. The vector as claimed in claim 6 , wherein a suitable promoter in operational orientation provides for expression of the gene of interest in the host organism. 8. The vector as claimed in claim 7 , wherein the suitable promoter is tac. 9. The vector as claimed in claim 5 , wherein the locus of interest comprises the PAM sequence 5′-NNNNCNN-3′ located 3′ of the target sequence. 10. The vector as claimed in claim 9 , wherein the locus of interest comprises a PAM sequence selected from SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 21 and SEQ ID NO: 22. 11. The vector as claimed in claim 4 , wherein the guide RNA is a single guide RNA (sgRNA). 12. A method of modifying the genetic material of an organism comprising transforming the organism with a first expression vector of claim 4 , and a second expression vector comprising a promoter and a polynucleotide sequence which encodes a homologous recombination (HR) fragment and which is under the transcriptional control of the promoter. 13. The method as claimed in claim 12 , wherein the transformed organism is cultured for a period at a first temperature, and then cultured at a second temperature before or during induction of the promoter of the ThermoCas9 sequence; wherein the first temperature is 60° C. or less and the second temperature is a higher temperature which is at least 55° C. 14. The method as claimed in claim 12 , wherein the organism is a prokaryote selected from the group consisting of: (a) a thermophilic bacterium, (b) a bacterium with growth temperature optimum of at least 40° C.; and (c) a soil bacterium. 15. A method of modifying the genetic material of a prokaryotic organism comprising transforming the organism with an expression vector of claim 4 . 16. A prokaryotic cell transformed with an expression vector of claim 1 . 17. A polynucleotide expression vector for modifying the genetic material at a target locus of a host organism which comprises the expression vector, the vector comprising: a) a polynucleotide sequence encoding a ThermoCas9 nuclease, wherein the ThermoCas9 nuclease comprises the amino acid sequence of SEQ ID NO: 1 or a sequence of at least 89% identity therewith, or an active fragment thereof; b) a polynucleotide sequence encoding a guide RNA, wherein the guide RNA has a nucleic acid sequence which recognizes a target nucleic acid sequence comprised in the target locus; c) a first promoter oriented with respect to polynucleotide sequence of (a) so as to drive expression thereof in the organism, wherein said first promoter is an inducible promoter; and d) a second promoter oriented with respect to polynucleotide sequence of (b) so as to drive expression thereof in the organism.

Assignees

Inventors

Classifications

  • Specially adapted vectors · CPC title

  • using homologous recombination · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • Mutagenizing nucleic acids · CPC title

  • in mammalian cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12071639B2 cover?
A polynucleotide encoding a ThermoCas9 protein from Geobacillus thermodenitrificans and a constitutive promoter are used to engineer eukaryotic cells, e.g. fungi, yeast or algae, so that the ThermoCas9 endonuclease is integrated and expressed from the genome of the cell. Then, a second expression plasmid is used to transfect these ThermoCas9 expressing cells, the second plasmid containing an …
Who is the assignee on this patent?
Univ Wageningen, Stichting Technische Wetenschappen
What technology area does this patent fall under?
Primary CPC classification C12N9/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).